Explore 3 Stock Ideas & Industry Insights Download Free Report
The recent annual meeting update reported weaker first-half revenue, lower gross margins and a tight cash position. Management introduced cost controls and was reviewing working-capital requirements. At the same time, preclinical antibody work produced encouraging animal-model findings, while international patent progress broadened technology protection. …
The latest interim update described progress with an improved lipid-based formulation of its lead programme and enrolment across initial dose-escalation cohorts. Management expects further safety and drug-exposure evidence before year-end. Earlier financing supported the transition into a clinical-stage business and its AIM admission. These …
Recent company announcements confirmed a multi-year US diagnostics collaboration and a completed fundraising intended to support its commercial rollout. The partnership is designed to broaden access to kidney risk testing through an established clinical network. The company has also announced a planned chair transition. …
• Abingdon Health Plc (LSE:ABDX) is being assessed against its latest disclosed business developments and sector drivers.
• Bioventix Plc (LSE:BVXP) is being assessed against its latest disclosed business developments and sector drivers.
• Coiled Therapeutics Plc (LSE:COIL) is being assessed against its latest disclosed business developments and sector drivers.
• Creo Medical Group Plc (LSE:CREO) is being assessed against its latest disclosed business developments and sector drivers.
• IXICO Plc (LSE:IXI) is being assessed against its latest disclosed business developments and sector drivers.
• Physiomics Plc (LSE:PYC) is being assessed against its latest disclosed business developments and sector drivers.
• Scancell Holdings Plc (LSE:SCLP) is being assessed against its latest disclosed business developments and sector drivers.
We use some essential cookies to make this site work. We also set analytics and marketing cookies, described below, to understand how you use the site and to measure our advertising. For more detailed information, see our Cookie Policy, Privacy Policy and Terms and Conditions.
These cookies are necessary for core functionality, such as security, your shopping cart, remembering your cookie choice, and your progress through a report or free-trial request you started. They always need to be on.
We use analytics cookies to understand how visitors use the site — the pages visited, time spent, and where visitors came from.
These help us measure how effective our advertising is, such as recording actions you take after clicking one of our ads. If you don't enable this, you may still see our ads, but they won't be measured this way.
Please wait processing your request...
You are not subscribed for this report, Want to See?
One of our sales representative will contact you soon!
Welcome to Kalkine!
Download Free Report
Hi! How can we help you today?
Loading…